Consolidated Statements of Income - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Revenues:
Rental and related revenues		$ 528,093	$ 515,373	$ 440,198
Interest income on real estate loans and other		15,370	11,262	17,501
Total revenues		543,463	526,635	457,699
Expenses:
Interest expense		81,351	72,234	60,136
General and administrative		38,756	40,209	37,757
Operating expenses		182,661	171,100	137,408
Depreciation and amortization		191,091	189,641	157,870
Merger and transaction-related expense	[1]	6,934	0
Impairment loss		0	0	340
Total expenses		500,793	473,184	393,511
Income before equity in income (loss) of unconsolidated entities and gain on sale of investment properties, net:		42,670	53,451	64,188
Equity in income (loss) of unconsolidated entities		1,084	(790)	(1,570)
Gain on sale of investment properties, net		13	57,375	24,165
Net income		43,767	110,036	86,783
Net income attributable to noncontrolling interests:
Operating Partnership		(1,722)	(5,240)	(2,211)
Partially owned properties	[2]	(169)	(430)	(607)
Net income attributable to controlling interest		41,876	104,366	83,965
Preferred distributions		0	0	(13)
Net income attributable to common shareholders		$ 41,876	$ 104,366	$ 83,952
Net income per share:
Basic (in dollars per share)		$ 0.18	$ 0.46	$ 0.39
Diluted (in dollars per share)		$ 0.17	$ 0.46	$ 0.39
Weighted average common shares:
Basic (in shares)		238,216,847	226,598,474	216,135,385
Diluted (in shares)		249,344,713	239,610,285	223,060,556
Dividends and distributions declared per common share (in dollars per share)		$ 0.92	$ 0.92	$ 0.92

[1] During the year ended December 31, 2023, the Company recorded merger and transaction-related expense of $6.9 million related to the proposed merger with Healthpeak, which are primarily comprised of legal, accounting, tax, and other costs incurred prior to year-end.

[2] Includes amounts attributable to redeemable noncontrolling interests.